menu
    • menu

    Company profile for Orna Therapeutics

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way we treat disease. Orna’s proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions.Built on groundbreaking research from Prof. Daniel Anderson’s lab at MIT, our ...
    Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way we treat disease. Orna’s proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions.Built on groundbreaking research from Prof. Daniel Anderson’s lab at MIT, our oRNATM technology is the next revolution in RNA therapeutics: synthetic circular RNA efficiently generated by an elegant and proprietary molecular platform.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Orna TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    620 Memorial Drive, 2nd Floor, Cambridge, MA 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ornatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ornatx/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/orna_tx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eli Lilly Acquires $2.4B Orna For CAR T Entry In Autoimmune
    Eli Lilly Acquires $2.4B Orna For CAR T Entry In Autoimmune

    09 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lilly-to-acquire-orna-therapeutics-to-advance-cell-therapies-302682157.html

    PR NEWSWIRE
    09 Feb 2026
    Share Share
    Simnova & Orna Expand Strategic Partnership for RNA Therapeutics
    Simnova & Orna Expand Strategic Partnership for RNA Therapeutics

    15 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/simnova-and-orna-expand-strategic-partnership-to-include-bcma-targeted-rna-therapeutics-302350951.html

    PR NEWSWIRE
    15 Jan 2026
    Share Share
    Orna Therapeutics: In Vivo CAR Data on Autoimmune Diseases
    Orna Therapeutics: In Vivo CAR Data on Autoimmune Diseases

    07 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orna-therapeutics-presents-new-data-supporting-its-in-vivo-car-programs-for-autoimmune-diseases-and-oncology-at-the-67th-american-society-of-hematology-annual-meeting-302634634.html

    PR NEWSWIRE
    07 Dec 2025
    Share Share
    Orna Pharma Showcase In Vivo CAR Programs For Autoimmune Diseases
    Orna Pharma Showcase In Vivo CAR Programs For Autoimmune Diseases

    03 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orna-therapeutics-announces-multiple-presentations-supporting-its-in-vivo-car-programs-for-autoimmune-diseases-at-the-67th-american-society-of-hematology-annual-meeting-302602492.html

    PR NEWSWIRE
    03 Nov 2025
    Share Share
    Orna Therapeutics Presents In Vivo CAR Therapy At Acr Meeting
    Orna Therapeutics Presents In Vivo CAR Therapy At Acr Meeting

    24 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orna-therapeutics-announces-encore-presentation-at-the-american-college-of-rheumatology-annual-meeting-supporting-its-in-vivo-car-therapy-approach-in-autoimmune-diseases-302593353.html

    PR NEWSWIRE
    24 Oct 2025
    Share Share
    Orna Therapeutics Names Joseph Bolen, Ph.D., CEO
    Orna Therapeutics Names Joseph Bolen, Ph.D., CEO

    31 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orna-therapeutics-appoints-joseph-bolen-phd-as-chief-executive-officer-302415137.html

    PR NEWSWIRE
    31 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search